Healthtech Capital Readiness Begins Before the Pitch
Healthtech rounds fail on documentation, reimbursement logic, and security posture — not on the deck. What readiness looks like when it is treated as an operating state.
Read the noteFor Companies
For deep-tech, healthtech, dual-use, and innovation-driven companies aligning non-dilutive, venture, and strategic capital around measurable technical and commercial milestones.
Failure Modes
These are the patterns that show up first, and the ones that cost the most to correct late.
Non-dilutive pursuit sits with a grants lead while the round sits with the CEO. Neither plan prices the other, so federal awards fund work the equity story never claims credit for.
The round is timed to a runway date rather than to the technical or commercial proof point that changes the valuation conversation.
Cap table, regulatory assumptions, reimbursement logic, security posture, and customer evidence are rebuilt for each investor instead of maintained as a standing asset.
Capital work is distributed across a founder, a consultant, and a part-time writer. No one is accountable for conversion across the whole stack.
What Forged Catalyst Builds
A written 24-month sequence that assigns every source — federal, venture, strategic, customer — a specific risk it is responsible for removing, with trigger points and owners.
Agency and program fit measured against the actual technical position, with go / no-go discipline so the team stops spending six-week blocks on low-probability submissions.
A maintained data room, cap-table integrity, and an evidence standard that survives institutional review — built once, reused across every capital conversation.
Embedded senior ownership of the integrated pipeline when capital complexity has outgrown founder-led execution.
Proof
A diligence-first capital readiness model built around live investor exposure rather than pitch practice. Eleven cohorts completed and 110 companies supported; alumni companies have reported raising more than $173M according to University City Science Center reporting.
Public program outcomes as reported by the program operator. Not represented as solely attributable to Forged Catalyst.
Inclusion reflects prior leadership, program, advisory, investment, or institutional work. It does not imply current endorsement, partnership, or client status.
Fitting Engagements
Companies running federal, venture, and strategic capital simultaneously typically need an owner before they need another advisor.
$4,750
A focused diagnostic identifying where capital conversion is breaking down, what is constraining progress and which interventions should be prioritized.
$10,000–$15,000
A decision-grade capital and commercialization strategy covering opportunity alignment, funding architecture, institutional positioning and execution priorities.
From $30,000
For complex federal pursuits, capitalization strategies, institutional programs, funds and multi-party initiatives.
Custom Retainer
Senior operating leadership for organizations that need sustained capital strategy, institutional alignment and execution without adding a full-time executive.
Related Insight
Healthtech rounds fail on documentation, reimbursement logic, and security posture — not on the deck. What readiness looks like when it is treated as an operating state.
Read the noteEngage
The Capital Strategy Diagnostic takes about ten minutes and returns a structured read on sequencing, evidence, and ownership gaps.